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Killing adherent and nonadherent cancer cells with the plasma pencil
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The application of low temperature plasmas in biology and medicine may lead to a paradigm
shift in the way various diseases can be treated without serious side effects. Low temperature
plasmas generated in gas mixtures that contain oxygen or air produce several chemically
reactive species that have important biological implications when they interact with eukaryotic
or prokaryotic cells. Here, a review of the effects of low temperature plasma generated by
the plasma pencil on different cancerous cells is presented. Results indicate that plasma
consistently shows a delayed killing effect that is dose dependent. In addition, there is
some evidence that apoptosis is one of the pathways that leads to the death of the cells,
indicating that plasma initiates cell signaling pathways. VC 2015 American Vacuum Society.
[http://dx.doi.org/10.1116/1.4905666]
I. INTRODUCTION
Plasma Medicine is a field of research that deals with
the biomedical applications of low temperature plasmas
(LTPs) and most specifically plasmas generated at atmos-
pheric pressure and at biologically tolerable tempera-
tures.1,2 These types of plasmas can be safely applied to
biological systems (cells, tissues, organs, etc.) without
causing thermal damage. The plasma can be tuned to
achieve various effects ranging from killing pathogens, to
stimulating the proliferation of healthy cells, to destroying
cancer cells.1–3 Tuning the plasma to achieve desired
effects involves judicious selection of the operating gas
mixture, the type of waveform of the applied voltage (DC,
pulsed DC, RF, pulsed RF, microwave, etc.), and careful
adjustment of the amount of applied power to influence the
electrons energy distribution function and to control the
fluxes of the reactive species. There is a general agree-
ment, based on overwhelming experimental evidence, that
the plasma-generated reactive oxygen species (ROS) and
reactive nitrogen species (RNS) play significant roles in
most of the observed effects of plasma on biological cells
and biological systems. This comes as no surprise as it is
well known from cell biology investigations that ROS and
RNS are involved in various biochemical events that occur
on the cellular and subcellular levels. Some of these
include lipids peroxidation, DNA damage, and the trigger-
ing of cellular signals.1–4
Of all the possible applications of LTP in medical therapy
none is expected to have as much of an important scientific
and societal impact as cancer treatment. Today, the work on
cancer is becoming the most exciting topic in plasma medi-
cine research. Here, first what is known about the mecha-
nisms of action of LTP against cancer cells is briefly
reviewed, then the results of the application of a particular
LTP source termed the “plasma pencil” to kill cancer cells
are presented.
II. MECHANISMS OFACTION OF LTPAGAINST
CANCER CELLS
In general, LTP is applied to cells that are either sub-
merged in a liquid medium or covered by a thin layer of a
liquid/fluid. Therefore, the reactive species generated by the
plasma in the gaseous state have to go through a gas–liquid
interface and then diffuse into the bulk of the liquid. Since
most plasma-generated reactive species are short-lived
whereas the plasma-induced biological effects on cells have
been observed only a relatively long time later, we hypothe-
size that the short lived species first react with the medium
to create reaction by-products that are long-lived and it is
these species that subsequently interact with the cells. These
longer-lived reaction byproducts would include H2O2,
NO2
, NO3
, RO2 (organic peroxide), etc. Our work showed
that if a medium is treated by LTP, then cells are seeded into
this plasma activated medium (PAM), the effects on the cells
greatly depends on the “age” of the PAM.5 By age it is
meant how long a time PAM is stored before applied on the
cells. The older the PAM, the lower the killing effect on
cells. Fresh PAM (not aged/applied right after plasma activa-
tion) has the strongest killing effect. Hence, we concluded
that plasma reaction byproducts in the medium are responsi-
ble for killing the cells, but as their concentrations decrease
with PAM storage/aging time (hours) most cells would be
able to cope and survive. It is important to note that the kill-
ing of cells by PAM occurs in a delayed manner, the same as
for the case when cells are directly exposed to LTP.
Based on experimental evidence, several investigators
reported that cancer cells appear to be more vulnerable
to LTP than their healthy counterparts.6,7 Keidar and co-
workers reported that LTP causes an increase in the expres-
sion of the oxidative stress reporter cH2A.X (pSer 139) and
a decrease in DNA replication in the S-phase of the cell
cycle.8 The S-phase is the phase in the cell cycle when DNA
replication occurs. These effects were much less pronounced
in the healthy cells. Since LTP appears to interfere with the
DNA replication phase and since cancer cells multiply more
rapidly than their healthy counterparts, they are much morea)Electronic mail: mlarouss@odu.edu
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susceptible to LTP-induced damage. In general, cancer cells
have much higher metabolic rate than healthy cells and
therefore exhibit higher levels of intracellular concentrations
of ROS and RNS. Hence, exposure of cancer cells to LTP
leads to an even higher intracellular oxidative stress, there-
fore causing their death.
Other investigators have reported that cell signaling plays
an important role in the interaction of LTP with cancer cells.
One such signaling pathway is the activation of caspases.
Caspases are proteins that play a crucial role in apoptosis or
programmed cell death. The lack of initiation of apoptosis
leads to uncontrolled cell multiplication and tumor
development.
Laroussi and co-workers studied caspase-3 activation in
the case of squamous cell carcinoma and found higher level
of caspase-3 activation in cells treated by LTP than in con-
trol samples (untreated cells), indicating that LTP induces
apoptosis in these cells.9 Ishaq et al. suggested that because
tumor cells are defective in several regulatory signaling
pathways they exhibit metabolic imbalance, which leads to a
lack of cell growth regulation.10 According to these authors,
LTP-generated ROS affect the metabolism of the cancer
cells by impairing redox balance, which leads to slowing
down or arresting the proliferation of the cells. These inves-
tigators also reported that LTP up-regulates intracellular
ROS levels and induce apoptosis in melanoma.11 They iden-
tified that LTP exposure causes a differential expression of
tumor necrosis factor (TNF) family members in the cancer-
ous cells but not in the normal cells. They found that apopto-
sis in the cancer cells was induced by apoptosis signal kinase
1 (ASK1), which is activated by TNF signaling.
III. PLASMA PENCIL
The application of LTP in biology and medicine relies on
the availability of various sources that can produce plasmas
with gas temperatures less than about 40 C, and at atmos-
pheric pressure (760 Torr). This is crucial since if LTP is
to be used as a basis for a medical therapy it has to be gener-
ated at surrounding room conditions such as in a hospital or
clinic setting. Among the various LTP sources, low tempera-
ture, atmospheric pressure plasma jets are most practical for
biomedical applications because they readily provide plas-
mas to a target at room conditions.12–14 These jets can be
powered by sources covering a wide frequency spectrum
that ranges from DC to microwaves. Various types of plasma
jets have therefore been developed with designs tailored for
specific needs. One such device, the plasma pencil, a hand-
held plasma jet generator developed in our laboratory, is pre-
sented here in some detail.
The electrodes of the plasma pencil are disk-shaped and
spaced by a gap that can be varied from 0.5 to1 cm (see Fig.
1).15 Each of the two electrodes is made of a thin copper ring
attached to the surface of a centrally perforated dielectric
disk. To ignite the plasma, high voltage (few kV) pulses at
repetition rates in the 1–10 kHz range are applied between
the two electrodes and a gas mixture (such as helium and ox-
ygen) is flown through the holes of the electrodes (flow rates
in the 1–10 l/min range). Plasma plumes reaching lengths up
to 5 cm can be launched through the hole of the outer elec-
trode and in the surrounding room air.15 The length of the
plume depends on the gas flow rate, the magnitude of the
applied voltage pulses, their widths, and the frequency. The
plasma plume exhibits low temperature and can be touched
by bare hands without causing any harm. A photograph of
the plume emitted by the plasma pencil and touching the
author’s hand is shown in Fig. 2. Since the plasma plume
does not cause thermal damage even to delicate tissue, it can
be applied to disinfect skin wounds resulting from cuts or
burns and to destroy cancer cells without damaging healthy
cells.
Using a combination of diagnostics involving intensified
charge coupled device imaging, optical emission spectros-
copy, and electrical probes it was discovered that the plasma
plume is in fact not a continuous volume of plasma, as they
appear to the naked eye, but discrete small volumes of
plasma referred to as “plasma bullets,” which travel at very
high velocities.16,17 Unlike regular plasma streamers, which
appear at random times and spaces, these plasma bullets ex-
hibit behavior that is highly repeatable and predictable. Lu
FIG. 1. Schematic of the plasma pencil.
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and Laroussi first proposed photoionization as a necessary
mechanism to explain the propagation of the plasma bul-
lets;17 however, today there is consensus that plasma bullets
are “guided” ionization waves where the electric field at the
head of the plasma bullet plays an important role in its prop-
agation characteristics.14
Because plasma bullets are launched in air, they produce
very interesting reactive chemistry that can be exploited in
biological and medical applications. Reactive oxygen spe-
cies, such as O, OH, O2
, and reactive nitrogen species,
such as NO, NO2, which are known to have biological
implications, are abundantly generated by the plasma
bullets.
IV. EFFECTS OF THE PLASMA PENCIL ON
CANCER CELLS
To investigate the efficacy of the plasma pencil against
cancer both adherent and nonadherent cancerous cells
were tested. As a representative of nonadherent cell lines
leukemia cells were selected. As adherent cells, squamous
cell carcinoma and prostate cancer cells were used. The
following is a review of the results obtained. The experi-
mental setup used in these studies is shown in Fig. 3. The
reader is hereby notified that the following is not a
review of the field but rather a review of our own results.
These results were originally published elsewhere, in var-
ious scientific journals. References to the original papers
are provided, where more details of the experiments can
be found. The remainder of this paper mainly summarizes
our work of the last few years on cancer application
using our low temperature plasma generator, the plasma
pencil.
A. Case of nonadherent cells
In this study, T-cell line (ATCC No. CCL-119; aka
CCRF-CEM) originally isolated from the blood of a patient
with acute lymphoblastic leukemia was used. The CCRF-
CEM cells are nonadherent leukemia cancer cells, obtained
from the American Type Culture Collection. They were
grown in complete growth media in 75 cm2 vented sterile
polystyrene tissue culture flasks at 37 C in a humidified
atmosphere containing 5% CO2. The growth media consisted
of buffered RPMI-1640 media supplemented with 10% fetal
bovine serum, 1% antibiotics (penicillin/streptomycin), and
1% glutamine.
Initial experiments revealed that plasma kills the leu-
kemia cells and that the effects of a single dose of
plasma continue for up to few days. Figures 4(a) and
4(b) illustrate results using CCRF-CEM leukemia cells,
in vitro, treated at various doses and evaluated at 12
and 36 h post-treatment, respectively.18 Figure 5 shows
images that illustrate the difference in color between
cells that took up the trypan blue dye (dead) and those
that did not (live).
The results revealed that the cell viability did not differ
dramatically at time 0 h postplasma treatment even at the
highest dose of treatment which was a plasma exposure of
10 min. However, when post-treatment analysis of cell via-
bility was determined at 12, 36, or 60 h, statistically signifi-
cant killing was observed even at the lower plasma doses.
Cell survivability data analyzed at 12, 36, or 60 h postplasma
treatment revealed that there was a threshold treatment time
of 3 min beyond which a highly statistically significant
increase in leukemia cell death was obtained.18 The results
from this study indicate that there is a dose dependent
response in the induction of cell death of leukemia cells and
single doses of plasma treatment continue killing cells up to
2.5 days post treatment. The delayed response of cell death
may be attributed to cell signaling cascades that may result
in apoptosis. However, for higher doses, such as for 10 min
exposure, necrotic cells were observed immediately after
plasma exposure.
FIG. 3. Experimental setup for the exposure of samples to the plasma pencil.
FIG. 2. Cold plasma plume touching the author’s hand.
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B. Case of adherent cells
1. Prostate cancer
The prostate cancer cells (DU 145) are metastatic cells
isolated from a patient’s brain, obtained from ATCC.
They have been conditioned to Roswell Park Memorial
Institute-1640 media supplemented with 10% fetal bovine
serum, 1% antibiotics (penicillin/streptomycin), and 1%
glutamine.
Cells were exposed to the plasma pencil in the same
manner as described above (see Fig. 3). At 0 h post-
treatment, plasma exposure times up to 10 min seemed not
to have an effect on the prostate cancer cells (DU 145).
However, starting with 24 h post-treatment, a slow but
steady trend of cell death for plasma exposure times longer
than 5 min was observed. Figure 6 shows cell viability in
percent versus plasma exposure time, 48 h post-treat-
ment.19 The figure shows that plasma exposure times less
than 5 min do not induce cell death at all. However,
starting around 5 min a slow decrease in viable cells is
observed as the exposure time increases. At a plasma expo-
sure time of 10 min, more than 20% of the cancer cells are
destroyed. Figure 7 shows images of the control DU 145
cells and that of cells treated for 10 min. The cells sample
exposed to plasma for 10 min shows extensive cell
damage.19
The delayed killing of cells (24 h and longer post-treat-
ment) indicates that the destruction of the cells is not
achieved by brute force at the time of plasma exposure. It
rather seems to indicate that plasma triggers biochemical
reactions that require some time to induce internal cellular
effects that can lead to cell death. If this hypothesis is correct
it would be consistent with cell signaling mechanisms asso-
ciated with apoptosis.
FIG. 5. Photograph of the trypan blue exclusion assay showing the live vs
dead cells after 3 min of exposure to plasma treatment sampled at 12 h post-
treatment. A ratio of 1:1 of the trypan blue dye (0.4% concentration) to 106
cells in media was used and the mixture was loaded on a hemocytometer.
The cells that are dead absorb the trypan blue dye while live cells do not.
The difference is clearly observed using a bright field microscope at a mag-
nification of 25.
FIG. 6. Percent viability vs exposure time for cancer cells. Data taken 48 h
postexposure.
FIG. 4. Effect of varying exposure time of plasma treatment on the viability
of CCRF-CEM cells. The cell viability was determined using trypan blue
exclusion assays, and the values are expressed as the mean percentage of
total viable cells 6 standard deviation of three separate experiments. (a)
Cell viability determined at 12 h postplasma treatment and (b) cell viability
determined at 36 h postplasma treatment.
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2. Squamous cell carcinoma
In this study, the human bladder cancer cell line SCaBER
(ATCCVR HTB3TM), originating from a patient with squa-
mous cell carcinoma, was used (see image in Fig. 8). These
type of cells are adherent with epithelial morphology. They
were grown in complete growth media in a vented tissue cul-
ture flask and were incubated at 37 C in a humidified atmos-
phere containing 5% CO2. The complete growth minimum
essential medium (MEM with 2mM Lglutamine and Earle’s
balanced salt solution) was adjusted to contain 10% fetal bo-
vine serum and 1% antibiotics (penicillin/streptomycin).
After adding 1 ml trypsin to the suspension of cells with a
concentration of 106 cells/ml, the suspension was trans-
ferred and seeded into the 24-well plate. The cells were incu-
bated overnight and adherence was monitored. Each sample
in the 24-well plate was treated by the plasma pencil at dif-
ferent exposure time. The distance from the tip of the nozzle
of the plasma pencil and the surface of the media was 2 cm.
The plasma exposure times were 2, 3.5, and 5 min, and the
untreated cells were kept as control for the cell viability
assays.
Trypan blue exclusion assay was used to determine the
viability of SCaBER cells. A ratio of 1:1 of the trypan blue
dye (0.4% trypan blue solution) to cells in MEM solution
was used. Cell counting (live versus dead) was carried out
by the use of a hemocytometer counting chamber under a
phase-contrast bright field microscope. The image of cells
after the trypan blue exclusion assay is shown in Fig. 9.
The dead cells retain the blue dye and are indicated by an
arrow, while the clear cells demonstrate live cells and are
indicated by a circle. The numbers of live and dead cells
were counted at 0, 12, 24, and 48 h postplasma exposure.
Subsequently, the total numbers of viable cells were
calculated.7
The results of cells viability are shown in Fig. 10.9 The
counts immediately after plasma pencil treatment at time 0 h
FIG. 7. Morphology of DU 145 cancer cells, control (a) and plasma treated
for 10 min (b).
FIG. 8. Image of untreated SCaBER cancer cells grown in MEM complete
growth media at a magnification of 10 using an inverted bright field
microscope.
FIG. 9. Image of SCaBER cells after the trypan blue exclusion assay show-
ing cells treated by LTP for 2 min at 12 h postplasma exposure. Live cells
are bright/whitish (indicated by the circle) as the dye cannot penetrate into
the intact cell membrane while dead cells are stained blue/dark (indicated by
the arrow). The image is at 10 magnification using a bright field
microscope.
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reveal no dead cells, suggesting that there were no immedi-
ate physical effects. However, the viability of cells at 24 h
after 2 min plasma treatment was reduced to 50%. For 5 min
plasma treatment, only about 25% of cells remained viable
at 24 h postplasma exposure, indicating that the higher the
dose of the plasma the lower the number of the cells that sur-
vived. The late effects of plasma at 48 h postplasma expo-
sure revealed higher efficacy of killing where, 5 min plasma
treatment diminished the viability of SCaBER cells to
approximately 10%.
Experiments were also conducted where the medium was
first treated by the plasma pencil and then the PAM was
added to the cells. The results were similar to the ones
described above when the cells were already in the medium
under plasma treatment.9 They indicate that the ROS, RNS,
and their derivatives/byproducts generated in the medium by
the plasma play a major role in the killing of the cells.
To test if cell signaling plays a role in leading to apoptosis
caspase-3 activation assay was used. Caspase-3 is a protein
involved in the apoptotic pathway that interacts with
caspase-8 and caspase-9 through a sequential process that
activates cell apoptosis. Monitoring the levels of caspase-3
is a good indicator of the apoptotic pathway activity. Results
from the caspase-3 activation assay suggested that the onset
of apoptosis occurs on or before 12 h postplasma exposure
and that 1 min of plasma treatment was the optimal dose for
eliciting the highest apoptotic activity based on the caspase-
3 levels in this study.9
The cells detachment/reattachment function was also
examined. Figure 11 shows images that provide a timeline of
cell detachment and reattachment after plasma exposure.9
From these images it is apparent that it takes longer time for
the cells to reattach to the surface of the flask as the plasma
FIG. 10. Cell viability of SCaBER cells treated in media reveal dead (dark
bars on top) and live (gray bars below). The viability was monitored for 0,
12, 24, and 48 h post-LTP exposure.
FIG. 11. Images of SCaBER cells reattaching to the surface of the culture plate at different times after reseeding. Photos were taken at specific times as noted
on each image. Panel A is the control SCaBER cells that were not treated. The untreated cells adhere and are responsive at 1.5 h post-reseeding. Panel B is a 2
min LTP treatment and panel C is a 5 min LTP treatment. The earliest reattachment time post-reseeding for the 5 min LTP treatment was at 4.5 h as indicated
by a few cells beginning to adhere to the surface.
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treatment time increases. In this case, as seen in Fig. 11, the
onset of reattachment of suspended SCaBER cells takes
place after 1.5, 3, and 4.5 h for LTP treatment times corre-
sponding to 0 (control), 2, and 5 min, respectively. This
result is an indication that LTP exposure affects the normal
function of the cell membrane ligands that allows it to attach
and adhere to surfaces.
V. CONCLUSIONS
This paper reviewed our experiments which used one of
our plasma jet generators, the plasma pencil, to evaluate the
effects of LTPs on various cancer cell lines. This line of
research has recently become of great interest to the plasma
medicine community since LTP appears to have most of the
desirable attributes that could lead to a new therapy. These
include selectivity, works as well in vivo, minimal side
effects, etc.
In our experiments, we tested, in vitro, both nonadherent
and adherent cells. LTP worked well for both types. All
experiments shared some consistent outcomes: (1) dose de-
pendency; (2) delayed effects by hours and days; and (3) sin-
gle exposures have measurable effects.
Since the cells were always in a suspension within a
growth medium, it is reasonable to assume that the plasma
interacts more directly with the medium than the cells them-
selves. Most of the reactive species generated by the plasma
are very short-lived and probably do not reach the actual
cells. Therefore, we think that these short-lived reactive spe-
cies react with the media, generating long-lived species that
cause the observed effects. These include H2O2, NO2
,
NO3
, RO2, etc. Since the observed effects only appear sev-
eral hours/days later, we hypothesize that these species
trigger biochemical events within the cells (intracellular)
that follow slow progressing cascades in cell signaling path-
ways. As possible evidence, caspase activation, which can
lead to apoptosis, was measured: For the case of SCaBER
cells, we were able to verify that under some conditions
caspase-3 was activated by LTP.
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